Clinical Guideline: PSA - Reported From The Annual Meeting Of The American Urological Association
Main Category: Prostate / Prostate CancerAlso Included In: Urology / Nephrology
Article Date: 19 Jun 2008 - 2:00 PDT
| Patient / Public: | ![]() |
3 (1 votes) |
| Healthcare Prof: | ![]() |
ORLANDO, FL (UroToday.com) - Dr. Kirsten Greene presented the PSA guidelines. The 2008 guidelines are an update from 2000. They performed a comprehensive literature review, had panel members review the articles then review them again under panel peer review. The consensus opinion is presently under final review. She presented the preliminary report.
It is a long process, as there are no prospective, randomized, controlled trials showing a survival benefit to CaP screening. The screening controversy is ongoing, but the NCCN, the AUA and the ACS support screening. Completion of screening trials in Europe and the US will facilitate the appropriate conclusions.
In 2000, age 50 was used to start screening, but age 40 is now being considered. The biopsy threshold was 4.0ng/ml, but a continuum of risk with a range of PSA is being considered. PSAV may be a better indicator of risk compared to an absolute value. African-American men should have screening earlier and PSA is more sensitive in younger men. Prostate volume, complexed PSA, free/total PSA, PSAD and PSA isoforms are under consideration. Risk stratification tables may facilitate a patient's decision regarding screening and biopsy. All these factors rather than a threshold value will be considered in the upcoming guidelines.
Presented by Kirsten L. Greene, MD, at the Annual Meeting of the American Urological Association (AUA) - May 17 - 22, 2008. Orange County Convention Center - Orlando, Florida, USA.
Reported by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to: www.urotoday.com
Copyright © 2008 - UroToday
Visit our prostate / prostate cancer section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/111877.php>
APA
http://www.medicalnewstoday.com/releases/111877.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




